SCHEMBL3105252

SCHEMBL3105252

O=C1CCNc2cc(F)ccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
ALDH1A1 P00352 2/20 0.54
HPGD P15428 2/20 0.54
LMNA P02545 1/20 0.54
TP53 P04637 1/20 0.54
POLB P06746 1/20 0.54
GAA P10253 1/20 0.54
ALOX15 P16050 1/20 0.54
ALOX12 P18054 1/20 0.54
CASP1 P29466 1/20 0.54
MPI P34949 1/20 0.54
HTT P42858 1/20 0.54
CASP7 P55210 1/20 0.54
HSD17B10 Q99714 1/20 0.54
PARP10 Q53GL7 2/20 0.50
PARP1 P09874 1/20 0.50
MAPT P10636 2/20 0.46
KDM4E B2RXH2 1/20 0.46
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30274589 1.00 MEN1 (0.54) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL11149678 0.85 MEN1 (0.58) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL6171659 0.78 MEN1 (0.54) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL6256563 0.78 MEN1 (0.54) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL29676514 0.78 MEN1 (0.54) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL4000581 0.78 MEN1 (0.54) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL16794237 0.78 MEN1 (0.54) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL10989615 0.78 ALDH1A1 (0.54) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL429558 0.77 PARP10 (0.54) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL30953872 0.77 PARP10 (0.54) MEN1KMT2AALDH1A1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222417-B2 Compound having 11β-HSD1 inhibitory activity TAISHO PHARMACEUTICAL CO., LTD (JP) 2012-07-17 US disclosed
US-20100179325-A1 COMPOUND HAVING 11BETA-HSD1 INHIBITORY ACTIVITY TAISHO PHARMACEUTICAL CO., LTD. (JP) 2010-07-15 US disclosed
EP-2172453-A1 COMPOUND HAVING 11 ß-HSD1 INHIBITORY ACTIVITY Taisho Pharmaceutical Co. Ltd. (JP) 2010-04-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179325-A1 COMPOUND HAVING 11BETA-HSD1 INHIBITORY ACTIVITY HSD11B1, CYP4A11, HSD11B2 MEN1 1895/4885KMT2A 1737/4885ALDH1A1 289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.